1. Home/
  2. Compounds/
  3. SNX-2112:bortezomib (250:1 mol/mol)

SNX-2112:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2SNX-2112:bortezomib (250:1 mol/mol)
PharmacoGx SNX-2112:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to SNX-2112:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA DDX55 CTRPv2 pan-cancer AAC 0.084 0.01
mRNA ZBED3 CTRPv2 pan-cancer AAC 0.089 0.01
mRNA CH17-360D5.1 CTRPv2 pan-cancer AAC -0.082 0.01
mRNA CUL7 CTRPv2 pan-cancer AAC -0.084 0.01
mRNA C18orf54 CTRPv2 pan-cancer AAC 0.085 0.01
mRNA EXD2 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA UBE2S CTRPv2 pan-cancer AAC 0.083 0.01
mRNA TP53TG3E CTRPv2 pan-cancer AAC -0.085 0.01
mRNA VEGFB CTRPv2 pan-cancer AAC -0.084 0.01
mRNA PAK1IP1 CTRPv2 pan-cancer AAC 0.082 0.01
Download CSV